| Literature DB >> 28877713 |
Maya Alsheh Ali1,2, Kamila Czene1, Louise Eriksson1,3, Per Hall1, Keith Humphreys4,5.
Abstract
BACKGROUND: Mammographic percentage density is an established and important risk factor for breast cancer. In this paper, we investigate the role of the spatial organisation of (dense vs. fatty) regions of the breast defined from mammographic images in terms of breast cancer risk.Entities:
Keywords: Adipose distribution; Breast cancer risk; Mammography; Spatial organisation
Mesh:
Year: 2017 PMID: 28877713 PMCID: PMC5586066 DOI: 10.1186/s13058-017-0894-6
Source DB: PubMed Journal: Breast Cancer Res ISSN: 1465-5411 Impact factor: 6.466
Fig. 1Examples of mammograms exhibiting different distributions of fatty and dense tissue. a The dense tissue is mainly located on the lower part of the breast. b The bulk of the dense tissue is concentrated in the retroareolar area. c The dense tissue is scattered but falls into two clusters, one next to the nipple and the other in the upper part of the breast
Fig. 2Illustration of the computation of FHs between two objects A (green) and B (orange). a Both objects and the parallel lines sweeping across the image oriented by a specific angle θ°. b The final FH (with angles between 0° and 360°) describing the spatial relationships between A and B. In this example, the maximum value of the FH is obtained for an angle of approximately 18° and is empty for values between 50° and 350°, since no line meets both objects A and B along these orientations. FH forces histogram
Fig. 3Overview of main analyses. A given breast image is first segmented into four regions: dense (red), semi-dense (yellow), semi-fatty (light blue) and fatty (dark blue) tissue. The spatial relations between each pair of regions is described by a forces histogram. The information captured by each forces histogram is compressed into a small number of variables using a functional principal component analysis and then the association between these variables (representing the spatial organisation of the regions) and breast cancer status is evaluated through a statistical test. PCA principal component analysis
Key characteristics of individuals (CAHRES)
| Characteristic | Cases | Controls |
|
|---|---|---|---|
| Number | 1,170 | 1,283 | |
| HRT use | 2×10−9 | ||
| Never | 791 (68%) | 998 (78%) | |
| Past | 98 (8%) | 40 (3%) | |
| Current | 281 (24%) | 245 (19%) | |
| Parity and AFB | 7×10−7 | ||
| Nulliparous | 157 (13%) | 129 (10%) | |
| Parity ≤2 and AFB ≤25 | 349 (30%) | 354 (28%) | |
| Parity ≤2 and AFB >25 | 372 (32%) | 351 (27%) | |
| Parity >2 and AFB ≤25 | 214 (18%) | 351 (27%) | |
| Parity >2 and AFB >25 | 78 (7%) | 98 (8%) | |
| Age | 62.6 (±6.5) | 63.6 (±6.4) | 8×10−5 |
| BMI | 25.2 (±3.6) | 25.0 (±3.8) | 0.26 |
| PD | 18.7 (±14.6) | 14.8 (±13.2) | 4×10−12 |
|
| 3.9 (±1.7) | 3.5 (±1.7) | 6×10−14 |
Means (with standard deviations in parentheses) are given for continuous variables and counts (with percentages in parentheses) are given for categorical variables. P values are obtained using likelihood ratio tests based on fitting logistic regression models without adjustment for additional covariates
AFB age at first birth, BMI body mass index, HRT hormone replacement therapy, PD percentage density
Logistic regression results with age, BMI, , parity and AFB, HRT and fPCs as covariates (CAHRES)
| Covariate | Estimated | Standard |
|
|---|---|---|---|
| coefficient | error | ||
| Intercept | −1.828 | 0.667 | 0.006 |
| Age | −0.008 | 0.007 | 0.259 |
| BMI | 0.066 | 0.015 | 2×10−5 |
|
| 0.199 | 0.040 | 6×10−7 |
| Parity and AFB | |||
| Nulliparous | |||
| Parity ≤2 and AFB ≤25 | −0.186 | 0.149 | 0.213 |
| Parity ≤2 and AFB >25 | −0.139 | 0.147 | 0.346 |
| Parity >2 and AFB ≤25 | −0.666 | 0.156 | 2×10−5 |
| Parity >2 and AFB >25 | −0.393 | 0.201 | 0.051 |
| HRT use | |||
| Never | |||
| Past | 0.737 | 0.201 | 2×10−4 |
| Current | 0.270 | 0.108 | 0.013 |
| Spatial relations fPCs a | |||
|
| −0.150 | 0.130 | 0.250 |
|
| −0.395 | 0.100 | 8×10−5 |
|
| 0.004 | 0.098 | 0.967 |
|
| 0.144 | 0.092 | 0.118 |
|
| −0.208 | 0.091 | 0.023 |
|
| 0.039 | 0.066 | 0.554 |
|
| 0.148 | 0.121 | 0.219 |
|
| 0.097 | 0.091 | 0.283 |
|
| −0.022 | 0.093 | 0.812 |
|
| 0.158 | 0.078 | 0.042 |
|
| 0.006 | 0.066 | 0.926 |
|
| 0.118 | 0.065 | 0.069 |
|
| 0.081 | 0.066 | 0.217 |
AFB age at first birth, BMI body mass index, HRT hormone replacement therapy, PD percentage density a p=2×10−7
Fig. 4Examples of mammograms with high ((a) and (b)) and low ((c) and (d)) values of . Original mammograms are shown next to their segmented regions 1 (dark blue) and 2 (light blue). Histograms of FH 12 values at angles of 54°, 152°and 268°are included above each image with the value for the specific image marked as a vertical red line. A low value, after adjustment for PD and other covariates, is associated with increased risk of breast cancer
Fig. 5Examples of mammograms with high ((a) and (b)) and low ((c) and (d)) values of . Original mammograms are shown next to their segmented regions 1 (dark blue) and 4 (red). The histograms of FH 14 at an angle of 192° are included above each image with the value for the specific image marked as a vertical red line. A low value, after adjustment for PD and other covariates, is associated with increased risk of breast cancer. PD percentage density
Linear regression model for with breast cancer risk factor covariates (CAHRES)
| Covariate | Estimated | Standard |
| |
|---|---|---|---|---|
| coefficient | error | |||
| Intercept | −1.332 | 0.272 | 1×10−6 | |
| Age | 0.003 | 0.003 | 0.373 | |
| BMI | 0.025 | 0.006 | 8×10−6 | |
| PD | 0.022 | 0.002 | < 2×10−16 | |
| Parity and AFB a | ||||
| Nulliparous | ||||
| Parity ≤2 and AFB ≤25 | 0.252 | 0.069 | 2×10−4 | |
| Parity ≤2 and AFB >25 | 0.100 | 0.068 | 0.142 | |
| Parity >2 and AFB ≤25 | 0.229 | 0.071 | 0.001 | |
| Parity >2 and AFB >25 | 0.108 | 0.093 | 0.243 | |
| HRT use | ||||
| Never | ||||
| Past | −0.121 | 0.089 | 0.175 | |
| Current | −0.074 | 0.050 | 0.140 |
Pearson product–moment correlation coefficients between and variables age, BMI and PD are −0.04 (p=0.05), −0.01 (p=0.82) and 0.25 (p<2×10−16), respectively
AFB age at first birth, BMI body mass index, HRT hormone replacement therapy, PD percentage density a p=6×10−4
Linear regression model for with breast cancer risk factor covariates (CAHRES)
| Covariate | Estimated | Standard |
|
|---|---|---|---|
| coefficient | error | ||
| Intercept | −2.24 | 0.260 | < 2×10−16 |
| Age | −0.003 | 0.003 | 0.224 |
| BMI | 0.078 | 0.005 | < 2×10−16 |
| PD | 0.028 | 0.001 | < 2×10−16 |
| Parity and AFB | |||
| Nulliparous | |||
| Parity ≤2 and AFB ≤25 | 0.052 | 0.066 | 0.420 |
| Parity ≤2 and AFB >25 | 0.086 | 0.065 | 0.188 |
| Parity >2 and AFB ≤25 | 0.015 | 0.068 | 0.826 |
| Parity >2 and AFB >25 | 0.004 | 0.089 | 0.959 |
| HRT use | |||
| Never | |||
| Past | −0.005 | 0.085 | 0.953 |
| Current | 0.016 | 0.048 | 0.732 |
Pearson product–moment correlation coefficients between and variables age, BMI and PD are −0.10 (p=8×10−7), 0.15 (p=7×10−14) and 0.29 (p<2×10−16) respectively
AFB age at first birth, BMI body mass index, HRT hormone replacement therapy, PD percentage density
Key characteristics of individuals (KARMA)
| Characteristic | Cases | Controls |
|
|---|---|---|---|
| Number | 69 | 231 | |
| HRT use | 0.179 | ||
| Never | 42 (61%) | 125 (54%) | |
| Past | 18 (26%) | 86 (37%) | |
| Current | 9 13%) | 20 (9%) | |
| Parity and AFB | 0.192 | ||
| Nulliparous | 9 (13%) | 26 (11%) | |
| Parity ≤2 and AFB ≤25 | 19 (27%) | 75 (33%) | |
| Parity ≤2 and AFB >25 | 24 (35%) | 66 (29%) | |
| Parity >2 and AFB ≤25 | 15 (22%) | 40 (17%) | |
| Parity >2 and AFB >25 | 2 (3%) | 24 (10%) | |
| Age | 63.06 (±6.05) | 60.95 (±6.71) | 0.021 |
| BMI | 25.93 (±4.48) | 25.37 (±3.65) | 0.283 |
| PD | 20.156 (±7.268) | 18.908 (±8.252) | 0.258 |
|
| 4.410 (±0.8481) | 4.238 (±.976) | 0.187 |
Means (with standard deviations in parentheses) are given for continuous variables and counts (with percentages in parentheses) are given for categorical variables. P values are obtained using likelihood ratio tests based on fitting logistic regression models without adjustment for additional covariates
AFB age at first birth, BMI body mass index, HRT hormone replacement therapy, PD percentage density
Logistic regression results with age, BMI, , Parity and AFB, HRT and fPCs as covariates (KARMA)
| Covariate | Estimated | Standard |
|
|---|---|---|---|
| coefficient | error | ||
| Intercept | −8.680 | 2.300 | 2×10−04 |
| Age | 0.072 | 0.024 | 0.002 |
| BMI | 0.070 | 0.046 | 0.128 |
|
| 0.388 | 0.186 | 0.037 |
| Parity and AFB | |||
| Nulliparous | |||
| Parity ≤2 and AFB ≤25 | −0.490 | 0.502 | 0.330 |
| Parity ≤2 and AFB >25 | −0.022 | 0.485 | 0.963 |
| Parity >2 and AFB ≤25 | −0.125 | 0.528 | 0.816 |
| Parity >2 and AFB >25 | −1.331 | 0.857 | 0.121 |
| HRT use | |||
| Never | |||
| Past | −0.772 | 0.347 | 0.026 |
| Current | 0.246 | 0.476 | 0.605 |
| Spatial relations fPCs | |||
|
| −0.344 | 0.160 | 0.031 |
|
| 0.243 | 0.160 | 0.128 |
AFB age at first birth, BMI body mass index, fPC Functional principal component, HRT hormone replacement therapy, PD percentage density